Acreozast
Alternative Names: TYB 2285Latest Information Update: 23 May 2000
At a glance
- Originator Toyobo
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antihistamines
- Mechanism of Action Histamine release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Atopic dermatitis
Most Recent Events
- 23 May 2000 Discontinued-II for Asthma in Japan (PO)
- 23 May 2000 Discontinued-II for Atopic dermatitis in Japan (PO)
- 15 Jul 1996 Phase-II clinical trials for Atopic dermatitis in Japan (PO)